Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Joint effects of polycyclic aromatic hydrocarbons, smoking, and XPC polymorphisms on damage in exon 2 of KRAS gene among young coke oven workers. | Front Public Health | 2022 | 35991047 | PubTator, text mining | PubMed |
| Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics. | Ther Adv Med Oncol | 2022 | 35983027 | PubTator, text mining | PubMed |
| Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers. | Cancer Res | 2022 | 35972384 | PubTator, text mining | PubMed |
| Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors. | J Exp Clin Cancer Res | 2022 | 35971164 | PubTator, text mining | PubMed |
| In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. | Transl Cancer Res | 2022 | 35966316 | PubTator, text mining | PubMed |
| The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 35963644 | PubTator, text mining | PubMed |
| Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes. | Antiviral Res | 2022 | 35963549 | PubTator, text mining | PubMed |
| Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma. | Int J Mol Sci | 2022 | 35955506 | PubTator, text mining | PubMed |
| Replication dependent and independent mechanisms of GAA repeat instability. | DNA Repair (Amst) | 2022 | 35952488 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Come on mtDNA, light my fire. | Immunity | 2022 | 35947975 | PubTator, text mining | PubMed |
| Role of m6A writers, erasers and readers in cancer. | Exp Hematol Oncol | 2022 | 35945641 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| DNA binding by the Rad9A subunit of the Rad9-Rad1-Hus1 complex. | PLoS One | 2022 | 35939452 | PubTator, text mining | PubMed |
| Novel interaction interfaces mediate the interaction between the NEIL1 DNA glycosylase and mitochondrial transcription factor A. | Front Cell Dev Biol | 2022 | 35938152 | PubTator, text mining | PubMed |
| ERCC5, HES6 and RORA are potential diagnostic markers of coronary artery disease. | FEBS Open Bio | 2022 | 35934844 | PubTator, text mining | PubMed |
| The 5'-phosphate enhances the DNA-binding and exonuclease activities of human mitochondrial genome maintenance exonuclease 1 (MGME1). | J Biol Chem | 2022 | 35934053 | PubTator, text mining | PubMed |
| The involvement of gut microbiota in the anti-tumor effect of carnosic acid via IL-17 suppression in colorectal cancer. | Chem Biol Interact | 2022 | 35926579 | PubTator, text mining | PubMed |
| To indel or not to indel: Factors influencing mutagenesis during chromosomal break end joining. | DNA Repair (Amst) | 2022 | 35926296 | PubTator, text mining | PubMed |
| Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks. | PLoS One | 2022 | 35913978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=38